OrganiGram Holdings (OGI)

OrganiGram Holdings Stock Analysis & Ratings


OGI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.90 - $2.78
Previous Close$1.24
Average Volume (3M)2.57M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-13.7
Next EarningsNov 30, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score7
EPS (TTM)-0.09
Shares Outstanding313,707,767
Standard Deviation0.20
10 Day Avg. Volume3,167,942
30 Day Avg. Volume2,574,416
P/B Ratio0.88
P/S Ratio2.56
P/CF Ratio2024.30
P/FCF Ratio-5.50
Total Debt$2.70M
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside35.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was OrganiGram Holdings’s price range in the past 12 months?
OrganiGram Holdings lowest stock price was $0.90 and its highest was $2.78 in the past 12 months.
    What is OrganiGram Holdings’s market cap?
    Currently, no data Available
    What is OrganiGram Holdings’s price target?
    The average price target for OrganiGram Holdings is $1.61. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $2.25 ,the lowest forecast is $1.16. The average price target represents 35.29% Increase from the current price of $1.19.
      What do analysts say about OrganiGram Holdings?
      OrganiGram Holdings’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
        When is OrganiGram Holdings’s upcoming earnings report date?
        OrganiGram Holdings’s upcoming earnings report date is Nov 30, 2022 which is in 105 days.
          How were OrganiGram Holdings’s earnings last quarter?
          OrganiGram Holdings released its earnings results on Jul 14, 2022. The company reported -$0.006 earnings per share for the quarter, beating the consensus estimate of -$0.015 by $0.009.
            Is OrganiGram Holdings overvalued?
            According to Wall Street analysts OrganiGram Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does OrganiGram Holdings pay dividends?
              OrganiGram Holdings does not currently pay dividends.
              What is OrganiGram Holdings’s EPS estimate?
              OrganiGram Holdings’s EPS estimate is -$0.02.
                How many shares outstanding does OrganiGram Holdings have?
                OrganiGram Holdings has 313,707,760 shares outstanding.
                  What happened to OrganiGram Holdings’s price movement after its last earnings report?
                  OrganiGram Holdings reported an EPS of -$0.006 in its last earnings report, beating expectations of -$0.015. Following the earnings report the stock price went down -2.778%.
                    Which hedge fund is a major shareholder of OrganiGram Holdings?
                    Currently, no hedge funds are holding shares in OGI


                    OrganiGram Holdings Stock Analysis

                    Smart ScoreNeutral
                    The OrganiGram Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    OrganiGram Holdings

                    OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

                    Similar Stocks
                    Price & Change

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis